Home » July / August 2022 » Recent trends in self-administered drug delivery systems – What does 2022 have in store for self-administered injectable drug delivery?
2022 | July / August 2022

Recent trends in self-administered drug delivery systems – What does 2022 have in store for self-administered injectable drug delivery?

by cyb2025
P. Hirst
Advanced delivery systems
COVID-19
drug delivery
Parenteral drug
Self-administration

PETER HIRST
Head of Commercial, Advanced Delivery Systems, Recipharm, Stockholm, Sweden

ABSTRACT

Peter Hirst, Head of Commercial, Advanced Delivery Systems at Recipharm, discusses the fast-changing pharmaceutical market landscape and explores the latest trends driving innovation in self-administered injectable drug delivery. Some trends that are pushing growth in this area are directly linked to the COVID-19 pandemic, including the need to ease the healthcare burden. These effects will continue to be felt well into 2022, so now is the time for pharmaceutical companies to take action in order to overcome the challenges self-administration brings about, and ensure that their technology puts them in the best position to create opportunities and benefits in this space.

According to a report released in January 2022, the global market for self-administered injectable drug delivery is expected to exceed more than US$119 billion by 2024, growing at a CAGR of 22.5% over the course of the forecast period (1).

ABOUT THE AUTHOR

Peter Hirst is Vice President, Commercial at Bespak by Recipharm. With over 25 years experience in the pharmaceutical industry, Peter brings a wealth of knowledge and experience to the Bespak by Recipharm team. Having completed a PhD in Cystic Fibrosis lung infections, Peter worked in a number of organisations supporting the development of pharmaceutical products that utilise drug delivery technologies. Peter has experience working across a range of organisations from small biotech start-ups to large pharma companies.

Latest issue

November /December 2025

View Issue

Archive

For an even more in-depth scientific analysis, consult the archive

Chemistry Today - Archive
Go to archive

Content from magazine

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.
View all content

Most popular

@2026 - All Right Reserved.

Login